2022 年 48 巻 5 号 p. 203-211
In 2010, we established the unified management system of side effects and allergy information of patients based on collaborative evaluation by pharmacists and clinicians. We collected and evaluated 1,700 cases (2,810 drugs) of side effects and allergy information over 8 years until 2017, and registered this information in the electronic medical records. In addition, this information is shared with all the medical staff in our hospital by electronic medical records, and is utilized to restrict and avoid the prescription of the drugs which are suspected to cause side effects or allergy (hereafter, the suspected drugs) for each patient.
Between April 2018 and March 2020, 24,361 patients were admitted to our hospital, of which 399 patients had the side effects and allergy information registered in the electronic medical records. Eighty-five of these patients were likely to receive the suspected drugs, but 84 of these 85 patients were changed to alternative drugs. In addition, the remaining one patient was safely administered the suspected drug after taking appropriate measures for side effects and allergies. Of the 84 patients who were able to avoid the suspected drugs, 64 patients were able to avoid them by the action of clinicians, and 20 patients were able to avoid them by the intervention of pharmacists. None of the patients received the suspected drugs by mistake, and all patients appropriately avoided them. The results of our research indicate that this management system is a useful means to ensure the safety of pharmacotherapy.
